Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hyperaldosteronism × Radiofrequency Ablation × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 17 Neoplasm Metastasis 11 Liver Neoplasms 8 Lung Neoplasms 6 Cholangiocarcinoma 6 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Barrett Esophagus 4 Recurrence 3 Rectal Neoplasms 3 Pain 3 Colonic Neoplasms 3 Biliary Tract Neoplasms 3 Prostatic Neoplasms 2 Leiomyoma 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Thyroid Cancer, Papillary 1 Thymoma 1 Squamous Intraepithelial Lesions 1 Small Cell Lung Carcinoma 1 Pancreatic cancer, adult 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Micrometastasis 1 Myoma 1 Mesothelioma, Malignant 1

Interventions

ziprasidone 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Radiofrequency Ablation 1 Prednisone 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Lurasidone Hydrochloride 1 Labetalol 1 Haloperidol 1 Fosfomycin 1 Dexamethasone 1 Clozapine 1 Ciprofloxacin 1 Cidofovir 1 Cefepime 1 Bosentan 1 Aminocaproic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02756754 2019-07-16

ADERADHTA

University Hospital, Toulouse

Phase NA Completed

ACTH Syndrome, Ectopic, Hyperaldosteronism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡